| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8605699 | Journal of Pain and Symptom Management | 2018 | 23 Pages |
Abstract
In this preliminary study, we found that the use of CES was safe and feasible in ACP. The use of CES was associated with significant improvement of depression, anxiety, pain, and sleep scores. These findings support further studies of CES in ACP for symptom control.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Sriram MD, MS, FAAHPM, Duck-Hee PhD, RN, FAAN, Wen-Jen MD, PhD, Nikhil S. PhD, Charles MS, Seyedeh S. PhD, Diane D. MS, Janet L. MPH, Zhanni MPH, Eduardo MD,